Search / 115 results found

from
to
  • Updated

ATLANTA, April 21, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders inside and outside of the brain, today announced that Milton Werner, Ph.D., President and Chief Executive Officer, will provide an update on clinical measures of dosing pharmacokinetics and elaborate on IKT-148009's mechanism of action at the Sachs 4th Annual Neuroscience Innovation Forum being held virtually on April 28-30, 2021.

  • Updated

CHARLOTTESVILLE, Va., April 21, 2021 /PRNewswire/ -- HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, has identified a second drug target for the treatment of gout under its collaboration with Horizon Therapeutics plc (Nasdaq: HZNP) that was established in January 2019. Leveraging its proprietary REVEAL-Tx™ disease modeling platform, HemoShear has earned two milestone payments to date in accordance with the Horizon exclusive drug discovery agreement. Each milestone acknowledges the validation of a novel drug target and its advancement to a subsequent stage in Horizon's early discovery pipeline.   

  • Updated

GREENVILLE, N.C., April 16, 2021 /PRNewswire/ -- Mayne Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS (3 mg drospirenone [DRSP] and 14.2 mg estetrol [E4] tablets) for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens.

  • Updated

BRUSSELS and ATLANTA, April 16, 2021 /PRNewswire/ -- UCB is pleased to announce that new data representing three neurological areas will be presented at the 73rd American Academy of Neurology (AAN) Annual Meeting, from 17-22 April 2021.1-9 Spanning across epilepsy and Parkinson's disease, posters being presented at this year's virtual meeting will highlight the latest scientific and clinical developments, as well as a patient-led analysis to demonstrate the experience of living with myasthenia gravis (MG).

  • Updated

SANFORD, N.C., April 8, 2021 /PRNewswire/ -- Friday, April 16, marks the third annual National Clean Out Your Medicine Cabinet Day. The designation, established by DisposeRx, Inc. is intended to remind people to go through their medicine cabinets, pantries, bedside tables, etc. to remove and properly dispose of expired and unused prescriptions, as well as over the counter and pet medications.